At the same time, effector T cells eradicate malignant cells through apoptotic signaling via Fas/FasL, secretion of granzyme and perforin, and direct lysis of tumor cell membrane, resulting in the release of extra tumor-associated antigens and cytokines that sustain tumor immune response in successive tumor immune cycles [31]. The gene discussed is PRF1; the disease is neoplasm.